Advertisement

Care for women with prior preterm birth

Published:April 26, 2010DOI:https://doi.org/10.1016/j.ajog.2010.02.004
      Women who have delivered an infant between 16 and 36 weeks' gestation have an increased risk of preterm birth in subsequent pregnancies. The risk increases with more than 1 preterm birth and is inversely proportional to the gestational age of the previous preterm birth. African American women have rates of recurrent preterm birth that are nearly twice that of women of other backgrounds. An approximate risk of recurrent preterm birth can be estimated by a comprehensive reproductive history, with emphasis on maternal race, the number and gestational age of prior births, and the sequence of events preceding the index preterm birth. Interventions including smoking cessation, eradication of asymptomatic bacteriuria, progestational agents, and cervical cerclage can reduce the risk of recurrent preterm birth when employed appropriately.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anotayanonth S.
        • Subhedar N.V.
        • Neilson J.P.
        • Harigopal S.
        Betamimetics for inhibiting preterm labour.
        Cochrane Database Syst Rev. 2006; 2 (CD004352)
        • King J.F.
        • Flenady V.
        • Papatsonis D.
        • Dekker G.
        • Carbonne B.
        Calcium channel blockers for inhibiting preterm labour.
        Cochrane Database Syst Rev. 2002; 3 (CD002255)
        • King J.F.
        • Flenady V.
        • Cole S.
        • Thornton S.
        Cyclo-oxygenase (COX) inhibitors for treating preterm labour.
        Cochrane Database Syst Rev. 2005; 2 (CD001992)
        • Crowther C.A.
        • Hiller J.E.
        • Doyle L.W.
        Magnesium sulphate for preventing preterm birth in threatened preterm labour.
        Cochrane Database Syst Rev. 2002; 4 (CD001060)
        • Papatsonis D.
        • Flenady V.
        • Cole S.
        • Liley H.
        Oxytocin receptor antagonists for inhibiting preterm labour.
        Cochrane Database Syst Rev. 2005; 3 (CD004452)
        • Iams J.D.
        • Newman R.B.
        • Thom E.A.
        • et al.
        Frequency of uterine contractions and the risk of spontaneous preterm delivery.
        N Engl J Med. 2002; 346: 250-255
        • Dyson D.C.
        • Danbe K.H.
        • Bamber J.A.
        • et al.
        Monitoring women at risk for preterm labor.
        N Engl J Med. 1998; 338: 15-19
        • American College of Obstetricians and Gynecologists (ACOG)
        ACOG practice bulletin no. 31.
        Obstet Gynecol. 2001; 98: 709-716
        • Sanchez-Ramos L.
        • Huddleston J.F.
        The therapeutic value of maintenance tocolysis: an overview of the evidence.
        Clin Perinatol. 2003; 30: 841-854
        • Shennan A.
        • Crawshaw S.
        • Briley A.
        • et al.
        A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fFN: the PREMET Study.
        BJOG. 2006; 113: 65-74
        • Andrews W.W.
        • Goldenberg R.L.
        • Hauth J.C.
        • Cliver S.P.
        • Copper R.
        • Conner M.
        Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial.
        Am J Obstet Gynecol. 2006; 194: 617-623
        • Vermeulen G.M.
        • Bruinse H.W.
        Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomized placebo-controlled double-blind trial.
        BJOG. 1999; 106: 652-657
        • Klebanoff M.A.
        • Carey J.C.
        • Hauth J.C.
        • et al.
        Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.
        N Engl J Med. 2001; 345: 487-493
        • Riggs M.A.
        • Klebanoff M.A.
        Treatment of vaginal infections to prevent preterm birth: a meta-analysis.
        Clin Obstet Gynecol. 2004; 47: 796-807
        • Thinkhamrop J.
        • Hofmeyr G.J.
        • Adetoro O.
        • Lumbiganon P.
        Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality.
        Cochrane Database Syst Rev. 2002; 4 (CD002250)
        • McDonald H.M.
        • Brocklehurst P.
        • Gordon A.
        Antibiotics for treating bacterial vaginosis in pregnancy.
        Cochrane Database Syst Rev. 2007; 1 (CD000262)
        • Andrews W.W.
        • Sibai B.M.
        • Thom E.A.
        • et al.
        Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.
        Obstet Gynecol. 2003; 101: 847-855
        • da Fonseca E.B.
        • Bittar R.E.
        • Carvalho M.H.
        • Zugaib M.
        Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous PTB in women at increased risk: a randomized placebo-controlled double-blind study.
        Am J Obstet Gynecol. 2003; 188: 419-424
        • Meis P.J.
        • Klebanoff M.
        • Thom E.
        • et al.
        Prevention of recurrent preterm delivery by 17-alpha-hydroxyprogesterone caproate.
        N Engl J Med. 2003; 348: 2379-2385
        • Spong C.Y.
        • Meis P.J.
        • Thom E.A.
        • et al.
        Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
        Am J Obstet Gynecol. 2005; 193: 1127-1131
        • Fonseca E.B.
        • Celik E.
        • Parra M.
        • et al.
        Progesterone and the risk of preterm birth among women with a short cervix.
        N Engl J Med. 2007; 357: 462-469
        • Rouse D.J.
        • Caritis S.N.
        • Peaceman A.M.
        • et al.
        A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.
        N Engl J Med. 2007; 357: 454-461
        • Caritis S.N.
        • Rouse D.J.
        • Peaceman A.M.
        • et al.
        Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
        Obstet Gynecol. 2009; 113: 285-292
        • Berghella V.
        • Odibo A.O.
        • To M.S.
        • Rust O.A.
        • Althuisius S.M.
        Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data.
        Obstet Gynecol. 2005; 106: 181-189
        • Owen J.
        • Hankins G.
        • Iams J.D.
        • et al.
        Multicenter randomized trial of cerclage for prevention of preterm birth in high-risk women with shortened mid-trimester cervical length.
        Am J Obstet Gynecol. 2009; 201: 375.e1-375.e8
        • Creinin M.
        • Simhan H.N.
        Can we communicate gravidity and parity better?.
        Obstet Gynecol. 2009; 113: 709-711
        • Iams J.D.
        • Goldenberg R.L.
        • Meis P.J.
        • et al.
        The length of the cervix and the risk of spontaneous premature delivery.
        N Engl J Med. 1996; 334: 567-573
        • Goldenberg R.I.
        • Thom E.
        • Moawad A.H.
        • et al.
        The preterm prediction study: fetal fibronectin, bacterial vaginosis and peripartum infection.
        Obstet Gynecol. 1996; 87: 656-660
        • Harris-Requejo J.
        • Merialdi M.
        The global impact of preterm birth.
        in: Berghella V. Preterm birth: prevention and management. Wiley-Blackwell, Oxford, UK2010: 1-7
      1. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2007. National vital statistics reports. Web release, vol 57, no 12. Hyattsville, MD: National Center for Health Statistics. Released March 18, 2009.

        • Petrini J.R.
        • Callaghan W.M.
        • Klebanoff M.
        Estimated effect of 17 alpha hydroxy-progesterone caproate on preterm birth in the United States.
        Obstet Gynecol. 2005; 105: 267-272
        • Edlow A.G.
        • Srinivas S.K.
        • Elovitz M.A.
        Second trimester loss and subsequent pregnancy outcomes: what is the real risk?.
        Am J Obstet Gynecol. 2007; 197: 581.e1-581.e6
        • Getahun D.
        • Lawrence J.M.
        • Fasset J.A.
        • et al.
        The association between stillbirth in the first pregnancy and subsequent adverse perinatal outcomes.
        Am J Obstet Gynecol. 2009; 201: 378.e1-378.e6
        • Henriet L.
        • Kaminski M.
        Impact of induced abortions on subsequent pregnancy outcome: the 1995 French national perinatal survey.
        BJOG. 2001; 108: 1036-1042
        • Ancel P.Y.
        • Lelong N.
        • Papiernik E.
        • et al.
        • EUROPOP
        History of induced abortion as a risk factor for PTB in European countries: results of the EUROPOP survey.
        Hum Reprod. 2004; 19: 734-740
        • Moreau C.
        • Kaminski M.
        • Ancel P.Y.
        • et al.
        • EPIPAGE Group
        Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study.
        BJOG. 2005; 112: 430-437
        • Shah P.S.
        • Zao J.
        • Knowledge Synthesis Group of Determinants of Preterm/LBW Births
        Induced termination of pregnancy and low birth weight and preterm birth: a systematic review and meta-analysis.
        BJOG. 2009; 116: 1425-1442
        • Jakobsson M.
        • Gissler M.
        • Sainio S.
        • et al.
        Preterm delivery after surgical treatment for cervical intraepithelial neoplasia.
        Obstet Gynecol. 2007; 109: 309-313
        • Van Voorhis B.J.
        Outcomes from assisted reproductive technology.
        Obstet Gynecol. 2006; 107: 183-200
        • Reddy U.M.
        • Wapner R.J.
        • Rebar R.W.
        • Tasca R.J.
        Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop.
        Obstet Gynecol. 2007; 109: 967-977
        • Shih W.G.
        • Rushford D.D.
        • Bourne H.
        • et al.
        Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection.
        Hum Reprod. 2008; 23: 1644-1653
        • Menard M.K.
        • Newman R.B.
        • Keenan A.
        • Ebeling M.
        Prognostic significance of prior preterm twin delivery on subsequent singleton pregnancy.
        Am J Obstet Gynecol. 1996; 174: 1429-1432
        • Facco F.L.
        • Nash K.
        • Grobman W.A.
        Are women who have had a preterm twin delivery at greater risk of preterm birth in a subsequent singleton pregnancy?.
        Am J Obstet Gynecol. 2007; 197: 253.e1-253.e3
        • Chandra S.
        • Scott H.
        • Dodds L.
        • et al.
        Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonaodtropin and the risk of adverse outcomes.
        Am J Obstet Gynecol. 2003; 189: 775-781
        • Shebl O.
        • Ebner T.
        • Sommergruber M.
        • et al.
        Birth weight is lower for survivors of the vanishing twin syndrome: a case-control study.
        Fertil Steril. 2008; 90: 310-314
        • Adams M.M.
        • Elam-Evans L.D.
        • Wilson H.G.
        • et al.
        Rates of and factors associated with recurrence of preterm delivery.
        JAMA. 2000; 283: 1591-1596
        • Esplin M.S.
        • O'Brien E.
        • Fraser A.
        • et al.
        Estimating recurrence risk of spontaneous preterm delivery.
        Obstet Gynecol. 2008; 112: 516-523
        • Kistka Z.A.F.
        • Palomar L.
        • Lee K.A.
        • et al.
        Racial disparity in the frequency of recurrence of PTB.
        Am J Obstet Gynecol. 2007; 196: 131.e1-131.e6
        • Mercer B.M.
        • Goldenberg R.L.
        • Moawad A.
        • et al.
        The preterm prediction study: effect of gestational age and cause of PTB on subsequent pregnancy outcome.
        Am J Obstet Gynecol. 1999; 181: 1216-1221
        • Mercer B.
        • Milluzzi B.
        • Collin M.
        Periviable birth at 20-26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk.
        Am J Obstet Gynecol. 2005; 193: 1175-1180
        • Mercer B.M.
        • Macpherson C.A.
        • Goldenberg R.L.
        • et al.
        Are women with recurrent spontaneous PTBs different from those without such history?.
        Am J Obstet Gynecol. 2006; 194: 1176-1185
        • McManemy J.
        • Cooke E.
        • Amon E.
        • et al.
        Recurrence risk for preterm delivery.
        Am J Obstet Gynecol. 2007; 196: 576.e1-576.e6
        • Goldenberg R.L.
        • Iams J.D.
        • Mercer B.M.
        • et al.
        The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous PTBs.
        Am J Public Health. 1998; 88: 233-238
        • Iams J.D.
        • Goldenberg R.L.
        • Mercer B.M.
        • et al.
        The preterm prediction study: recurrence risk of spontaneous PTB.
        Am J Obstet Gynecol. 1998; 178: 1035-1040
        • Kaltreider D.F.
        • Kohl S.
        Epidemiology of preterm delivery.
        Clin Obstet Gynecol. 1980; 23: 17-31
        • Carr-Hill
        • Hall M.H.
        The repetition of spontaneous preterm labour.
        Br J Obstet Gynaecol. 1985; 92: 921-928
        • Kagan K.O.
        • To M.
        • Tsoi E.
        • Nicolaides K.H.
        Preterm birth: the value of sonographic measurement of cervical length.
        BJOG. 2006; 113 (Review). Erratum in: BJOG 2008;115:674-5: 52-56
        • Celik E.
        • To M.
        • Gajewska K.
        • Smith G.C.S.
        • Nicolaides K.H.
        Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized assessment.
        Ultrasound Obstet Gynecol. 2008; 31: 549-554
        • Berghella V.
        • Roman A.
        • Daskalakis C.
        • et al.
        Gestational age at cervical length measurement and incidence of preterm birth.
        Obstet Gynecol. 2007; 110: 311-317
        • Durnwald C.P.
        • Walker H.
        • Lundy J.C.
        • Iams J.D.
        Rates of recurrent preterm birth by obstetrical history and cervical length.
        Am J Obstet Gynecol. 2005; 193: 1170-1174
        • Crane J.M.G.
        • Hutchens D.
        Use of transvaginal ultrasonography to predict preterm birth in women with a history of PTB.
        Ultrasound Obstet Gynecol. 2008; 32: 640-645
        • Lumley J.
        • Chamberlain C.
        • Dowswell T.
        • et al.
        Interventions for promoting smoking cessation during pregnancy.
        Cochrane Database Syst Rev. 2009; 3 (CD001055)
        • Polakowski L.L.
        • Akinbami L.J.
        • Mendola P.
        Prenatal smoking cessation and the risk of delivering preterm and small-for-gestational-age newborns.
        Obstet Gynecol. 2009; 114: 318-325
        • Smaill F.
        Antibiotics for asymptomatic bacteriuria in pregnancy.
        Cochrane Database Syst Rev. 2001; 2 (CD000490)
        • Meis P.J.
        • Society for Maternal-Fetal Medicine
        17 Hydroxyprogesterone for the prevention of preterm delivery.
        Obstet Gynecol. 2005; 105: 1128-1135
        • Dodd J.M.
        • Flenady V.
        • Cincotta R.
        • Crowther C.A.
        Prenatal administration of progesterone for preventing PTB.
        Cochrane Database Syst Rev. 2006; 1 (CD004947)
        • Northen A.T.
        • Norman G.S.
        • Anderson K.
        • et al.
        Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo.
        Obstet Gynecol. 2007; 110: 865-872
        • Rai P.
        • Rajaram S.
        • Goel N.
        • Gopalakrishnan R.A.
        • Agarwal R.
        • Mehta S.
        Oral micronized progesterone for prevention of preterm birth.
        Internat J Gynecol Obstet. 2009; 104: 40-43
        • O'Brien J.M.
        • Adair C.D.
        • Lewis D.F.
        • et al.
        Progesterone vaginal gel for the reduction of recurrent PTB: primary results from a randomized, double-blind, placebo-controlled trial.
        Ultrasound Obstet Gynecol. 2007; 30: 687-696
        • Facchinetti F.
        • Paganelli S.
        • Comitini G.
        • et al.
        Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate.
        Am J Obstet Gynecol. 2007; 196: 453.e1-453.e4
        • Owen J.
        • Szychowski J.
        • Hankins G.
        • et al.
        Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women?.
        Am J Obstet Gynecol. 2010; (In press.)
        • Althuisius S.M.
        • Dekker G.A.
        • van Geijn H.P.
        • Bekedam D.J.
        • Hummel P.
        Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results.
        Am J Obstet Gynecol. 2000; 183: 823-829
        • Simcox R.
        • Seed P.T.
        • Bennett P.
        • et al.
        A randomized controlled trial of cervical scanning vs history to determine cerclage in women at high risk of preterm birth (CIRCLE trial).
        Am J Obstet Gynecol. 2009; 200: 623.e1-623.e6
        • Kassanos D.
        • Salamalekis E.
        • Vitoratos N.
        • Panayotopoulos N.
        • Loghis C.
        • Creatsas C.
        The value of transvaginal ultrasonography in diagnosis and management of cervical incompetence.
        Clin Exp Obstet Gynecol. 2001; 28: 266-268
        • Mercer B.
        • Egerman R.
        • Beazley D.
        • et al.
        Antenatal corticosteroids in women at risk for preterm birth: a randomized trial.
        Am J Obstet Gynecol. 2001; 184: S6
        • Garite T.J.
        • Kurtzman J.
        • Maurel K.
        • et al.
        Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial.
        Am J Obstet Gynecol. 2009; 200: 248.e1-248.e9
        • Gomez R.
        • Galasso M.
        • Romero R.
        • et al.
        Ultrasonographic examination of the cervix is better than cervical digital examination as a predictor of preterm delivery in patients with preterm labor and intact membranes.
        Am J Obstet Gynecol. 1994; 171: 956
        • Goldberg J.
        • Newman R.B.
        • Rust P.F.
        Interobserver reliability of digital and endovaginal ultrasonographic cervical length measurements.
        Am J Obstet Gynecol. 1997; 177: 853
        • Althuisius S.M.
        • Dekker G.A.
        • Hummel P.
        • van geijn H.P.
        Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone.
        Am J Obstet Gynecol. 2003; 189: 907-910
        • Pereira L.
        • Cotter A.
        • Gómez R.
        • et al.
        Expectant management compared with physical examination-indicated cerclage (EM-PEC) in selected women with a dilated cervix at 14(0/7)-25(6/7) weeks: results from the EM-PEC international cohort study.
        Am J Obstet Gynecol. 2007; 197: 483.e1-483.e8
        • MCR/RCOG Working Party on Cervical Cerlage
        Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cerclage.
        Br J Obstet Gynecol. 1993; 100: 516-523
        • Rush R.W.
        • Issacs S.
        • McPherson K.
        • Jones L.
        • Chalmers I.
        • Grant A.
        A randomized controlled trial of cervical cerclage in women at high risk of preterm delivery.
        Br J Obstet Gynecol. 1984; 91: 724-730
        • Lazar P.
        • Gueguen S.
        • Dreyfus J.
        • Renaud R.
        • Pontonnier G.
        • Papiernik E.
        Multicentre controlled trial of cervical cerclage in women at moderate risk of preterm delivey.
        Br J Obstet Gynecol. 1984; 91: 731-735
        • Pelham J.
        • Lewis D.
        • Berghella V.
        Prior cerclage: to repeat or not to repeat?.
        Am J Perinat. 2008; 25: 417-420
        • Davis G.
        • Berghella V.
        • Talucci M.
        • Wapner R.J.
        Patients with a prior failed transvaginal cerclage: a comparison of obstetric outcomes with either transabdominal or transvaginal cerclage.
        Am J Obstet Gynecol. 2000; 183: 836-839
        • Sosa C.
        • Althabe F.
        • Belizán J.
        • Bergel E.
        Bed rest in singleton pregnancies for preventing PTB.
        Cochrane Database Syst Rev. 2004; 1 (CD003581)
        • Hobel C.J.
        • Ross M.G.
        • Bermis R.L.
        • et al.
        The West Los Angeles preterm birth prevention project. I. Program impact on high-risk women.
        Am J Obstet Gynecol. 1994; 170: 54-62
        • Olsen S.F.
        • Secher N.J.
        • Tabor A.
        • Weber T.
        • Walker J.J.
        • Gluud C.
        Randomized clinical trials of fish oil supplementation in high risk pregnancies.
        Br J Obstet Gynecol. 2000; 107: 382-395
        • Harper M.
        • Thom E.
        • Klebanoff M.A.
        • et al.
        Omega-3 fatty acid supplementation to prevent recurrent preterm birth.
        Obstet Gynecol. 2010; 115: 234-242
        • Hodnett E.D.
        • Fredericks S.
        Support during pregnancy for women at increased risk of low birthweight babies.
        Cochrane Database Syst Rev. 2003; 3 (CD000198)
        • Mueller-Heubach E.
        • Riddick D.
        • Barnett B.
        • Bente R.
        Preterm birth prevention: evaluation of a prospective controlled trial.
        Am J Obstet Gynecol. 1989; 160: 1172-1178
        • Main D.M.
        • Richardson D.K.
        • Hadley C.B.
        • Gabbe S.G.
        Controlled trial of a preterm labor detection program: efficacy and costs.
        Obstet Gynecol. 1989; 74: 873-877
        • Collaborative Group on Preterm Birth Prevention
        Multicenter randomized controlled trial of a preterm birth prevention program.
        Am J Obstet Gynecol. 1993; 169: 352-366
        • Levine R.J.
        • Hauth J.C.
        • Curet L.B.
        • et al.
        Trial of calcium to prevent preeclampsia.
        N Engl J Med. 1997; 337: 69-76
        • Hofmeyer G.J.
        • Atallah A.N.
        • Duley L.
        Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.
        Cochrane Database Syst Rev. 2006; 3 (CDC001059)
        • Kramer M.S.
        • Kakuma R.
        Energy and protein intake in pregnancy.
        Cochrane Database Syst Rev. 2003; 43 (CD000032)
        • Hauth J.C.
        • Goldenberg R.I.
        • Andrews W.W.
        • et al.
        Reduced incidence of preterm delivery with metronidazole and erthromycin in women with bacterial vaginosis.
        N Engl J Med. 1995; 333: 1732-1736
        • McDonald H.M.
        • O'Loughlin J.A.
        • Vigneswaran R.
        • et al.
        Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis:flora (Garnerella vaginalis): a randomized, placebo controlled trial.
        Br J Obstet Gynaecol. 1997; 104: 1391-1397
      2. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 200:342:534-40.

        • Gighangi P.B.
        • Ndinya-Achola J.O.
        • Ombete J.
        • et al.
        Antimicrobial prophylaxis in pregnancy: a randomized, placebo-controlled trial with cefetamet-pivoxil in pregnant women with poor obstetrical history.
        Am J Obstet Gynecol. 1997; 177: 680-684
        • Rumbold A.R.
        • Crowther C.A.
        • Haslam R.R.
        • et al.
        Vitamins C and E and the risks of preeclampsia and perinatal complications.
        N Engl J Med. 2006; 354: 1796-1806
        • Poston L.
        • Briley A.L.
        • Seed P.T.
        • et al.
        Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.
        Lancet. 2006; 367: 1145-1154
        • Dodd J.M.
        • Crowther C.A.
        • Dare M.R.
        • Middleton P.
        Oral betamimetics for maintenance therapy after threatened preterm labour.
        Cochrane Database Syst Rev. 2006; 1 (CD003927)
        • Whitworth M.
        • Quenby S.
        Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies.
        Cochrane Database Syst Rev. 2008; 1 (CD006395)
        • Gaunekar N.N.
        • Crowther C.A.
        Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour.
        Cochrane Database Syst Rev. 2004; 3 (CD004071)
        • Michalowicz B.S.
        • Hodges J.S.
        • Di Angelis A.J.
        • et al.
        Treatment of periodontal disease and the risk of preterm birth.
        N Engl J Med. 2006; 355: 1885-1894
        • Offenbacher S.
        • Beck J.
        • Jared H.
        • et al.
        Effects of periodontal therapy onrate of preterm delivery: a randomized-controlled trial.
        Obstet Gynecol. 2009; 114: 551-559
        • Macones G.A.
        • Parry S.
        • Nelson D.B.
        • et al.
        Treatment of local periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS).
        Am J Obstet Gynecol. 2010; 202: 147.e1-147.e8
        • Newnham J.P.
        • Newnham I.A.
        • Ball C.M.
        • et al.
        Treatment of periodontal disease during pregnancy: a randomized controlled trial.
        Obstet Gynecol. 2009; 114: 1239-1248
        • Moore M.L.
        • Meis P.J.
        • Ernest J.M.
        • et al.
        A randomized trial of nurse intervention to reduce preterm and low birth weight births.
        Obstet Gynecol. 1998; 91: 656-661
        • Newman R.B.
        • Sullivan S.A.
        • Menard M.K.
        • et al.
        South Carolina Partners for Preterm Birth Prevention: a regional perinatal initiative for the reduction of premature birth in a Medicaid population.
        Am J Obstet Gynecol. 2008; 199: 393.e1-393.e8
        • Berghella V.
        Novel developments on cervical length screening and progesterone for preventing preterm birth.
        BJOG. 2009; 116: 182-187

      Linked Article

      • Care for women with prior preterm birth
        American Journal of Obstetrics & GynecologyVol. 204Issue 3
        • Preview
          Iams and Berghella's recent article in the August 2010 issue on the care of women with prior preterm birth was comprehensive and helpful.1 They comment on the association of preterm birth with a prior history of elective abortion.
        • Full-Text
        • PDF